中肽生化目录肽版块全新呈现，致力于打造全球最全面的多肽供应平台！我们专业的学术团队将时刻追踪最新最热的研究动向，帮助您发现实际需求，并以最高质量标准提供您所需要的产品。我们将我们将不定期更新产品列表，为您最大限度地节约科研时间，敬请广大客户朋友关注！
PARP-001A
PAR-2 (1-6) amide (human) (scrambled)
Leu-Ser-Ile-Gly-Lys-Val-NH2 Trifluoroacetate salt
Leu-Ser-Ile-Gly-Lys-Val-NH2 Trifluoroacetate salt
Size：1mg
P1(RMB)：808
MW：614.79
One letter sequence：LSIGKV-NH2
Molecular Formula：C28H54N8O7
Description：This peptide is a partially reversed human PAR-2 activating peptide serving as an inactive control for the PAR-2 agonist SLIGKV-amide.
Literature Reference：H.Nishikawa et al., J. Pharmacol. Exp. Ther., 312, 324 (2005) I.A. Akers et al.,Am. J. Physiol. Lung Cell. Mol. Physiol., 278, L193 (2000). S. Miyata, et al., J. Biol. Chem., 275, 4592 (2000). S. Miike, A.S. McWilliam, and H. Kita, J. Immunol., 167, 6615 (2001).
Cas：
P1(RMB)：808
MW：614.79
One letter sequence：LSIGKV-NH2
Molecular Formula：C28H54N8O7
Description：This peptide is a partially reversed human PAR-2 activating peptide serving as an inactive control for the PAR-2 agonist SLIGKV-amide.
Literature Reference：H.Nishikawa et al., J. Pharmacol. Exp. Ther., 312, 324 (2005) I.A. Akers et al.,Am. J. Physiol. Lung Cell. Mol. Physiol., 278, L193 (2000). S. Miyata, et al., J. Biol. Chem., 275, 4592 (2000). S. Miike, A.S. McWilliam, and H. Kita, J. Immunol., 167, 6615 (2001).
Cas：
